Zeyue Zhang
Chairman / CEO
Read more
Shu Li
Founder / Co-Chairman
Read more
Meng Ding
COO
Read more
Jianfeng Xu
Vice President of Technology
Read more
Wei Li
Director / Principal Bioinformatics Consultant
Read more
Sufang Zhang
Registration / Vice President of Quality
Read more
Yifan Yuan
Vice President of Marketing
Read more
DianGe Li
R&D Director
Read more
Shu Li
Founder / Co-Chairman
Dr. Li is a successful serial entrepreneur in the biomedical field, having founded four biomedical companies that have successfully gone public or been exited by M&A to date. Under the innovative entrepreneurial model incubated by Dr. Li, he founded and accelerated the success of WA Zhenjing Medical M&A into Akcome Guobin, Cibiman Bio (NASDAQ:CBMG), Global Health Investment, Lyman Health LAMH, and Yuge Medical. Dr. Li has been an executive with several of the world's top 500 companies, including Senior Vice President of Cosmos Systems (NASDAQ: CNXT), Vice President and General Manager of Honeywell Commercial Spares, and held executive positions at Motorola and Intel Corporation. Dr. Li is a member of the Advisory Board of the Paul Merage School of Business at the University of California, Irvine, and has served on the faculty of the University of Arizona and holds six U.S. and international patents.
B.S. in Automation from Huazhong University of Science and Technology.
MSEE degree in Electrical Engineering from the University of IllinoisUrbana-Champaign (UIC).
Ph.D. in Applied Science from Harvard University.
Zeyue Zhang
Chairman / CEO
Mr. Zeyue Zhang has rich biotechnology background in commercialization, clinical medicine and genetic industry.background in commercialization, clinical medicine and biotechnology in the genetic industry; he has management experience in start-up companies, multinational companies, well-known private companies and state-owned enterprises. He has comprehensive experience in overall management and marketing system management.
He has worked for well-known domestic gene companies such as UW Genetics and Boao Testing, and has realized the development of gene testing IVD products and LDT services.
IVD products and LDT services (government, hospital, enterprise He has also worked for UW Genetics, Boao Testing and other well-known genetic companies in China, and has achieved rapid commercialization success by building multiple channels (government, hospitals, enterprises and consumers) for genetic testing IVD products and LDT services. He has worked for Lilly, Roche and Novartis.He has worked in the sales departments of well-known multinational pharmaceutical companies such as Lilly, Roche and Novartis, focusing on oncology, and has gained rapid success in oncology drug sales.
He has built strong relationships with hospitals, experts, associations and companies in the oncology field.
He has established deep connections with hospitals, experts, associations and companies in the oncology field.
Bachelor of Medicine from Southern Medical University.
Executive Master of Business Administration (EMBA) from China Europe International Business School (CEIBS).
Meng Ding
COO
Ms. Ding has a background in medical and genomic research, and has 12 years of experience in research and clinical, product and marketing in the oncogenomic industry.
Ms. Ding has worked in Boao Bio, Yuancode Genetics, PLA 307 Hospital, and Huasheng Hengye, where she held various positions including Product Director and Marketing Director.
Bachelor of Science degree from Peking University Medical Department.
Master's degree in Molecular Biology, Institute of Genome Research, Chinese Academy of Sciences.
Jianfeng Xu
Vice President of Technology
Dr. Jianfeng Xu is a bioinformatician and AI expert whose work on CHALM methylation algorithm and early screening for pan-digestive cancers was published in Nature Communications and Clinical Cancer Research, respectively.
B.S. in Life Sciences, Peking University.
PhD in Bioinformatics from Baylor College of Medicine.
Yifan Yuan
Vice President of Marketing
Mr. Yuan has rich experience in pharmaceutical clinical promotion and IVD/LDT marketing management. He has experience in state-owned listed companies, multinational foreign companies, and high-tech start-up companies, and is good at leading teams to establish efficient marketing systems to drive high business growth.
He has worked for Roche, Novartis, Daan Genetics, DareGlobal and Yuze Biologics in various positions, including Vice President, Business Unit General Manager, Marketing Director, Regional Director and Product Manager.
He holds a Bachelor's degree in Pharmaceutical Business Management from China Pharmaceutical University.
Sufang Zhang
Registration / Vice President of Quality
Ms. Zhang is familiar with Chinese medical device registration regulations and has 12 years of experience in IVD product registration.
Ms. Zhang started her career in medical device registration filing in 2010, and has worked for Fujirebio Corporation, Abbott, WuXi AppTec, Illimina and UW. The products involved are instruments and reagents for biochemistry, immunology, blood cell, and second-generation sequencing, PCR products, etc., covering Class I, II, and III products, as well as active devices. Participated in the development and validation of industry standards for testing organizations, and has participated in industry standards including: kits for lactogen, FSH, T3, rubella virus IgG/IgM, high-throughput sequencers, etc.
Bachelor of Medicine, School of Public Health, Sun Yat-sen University.
Master of Business Administration, China Agricultural University.
DianGe Li
R&D Director
Ms. Diange Li is one of the core developers of "Tumor Methylation Liquid Biopsy + Multi-omics Combination Diagnostic Products"; she has 5 years of experience in benchmark medicine research and development, early tumor screening and companion diagnostic liquid biopsy product development research and clinical testing experience ; Worked at BGI, with nearly 10 years of experience in high-throughput sequencing technology development, product design and operation, leading the team to develop and operate multi-clinical scene detection products and multi-omics detection products for multiple cancer types.
Master degree in Molecular Biology from Nankai University.
Wei Li
Director / Principal Bioinformatics Consultant
Dr. Wei Li is a Professor of Bioinformatics at the Center for Bioinformatics at the University of California, Irvine School of Medicine; formerly a Professor of Bioinformatics at Baylor College of Medicine and recipient of the Michael E. DeBakey Award for Excellence in Research, Baylor's highest honor. He has published more than 200 articles in prestigious international journals, including 23 as corresponding authors in Nature, Science, Cell and their subjournals, with an H-index of 85 and 54 citations. index up to 85 and 54,172 citations.
D. degree from the Institute of Biophysics, Chinese Academy of Sciences.
Founding member of the bioinformatics team at UWM.
Postdoctoral Fellow, Dana Farber Cancer Research Center, Harvard University (Harvard).